Rita Horvath, Clinical Director of Research at Addenbrooke’s Hospital, Cambridge, has spent over 25 years developing using genomics and biochemistry to diagnose rare, inherited neurological disorders. She has had significant translational impact throughout this time, enabling genetic counselling and prevention through precision genetic approaches.
She has established extensive international collaborations, having impact in low to middle income countries, showing her clinical and genetic expertise is having impact way beyond patients in the NHS.
She has developed two clinical services which span inherited neurological disorders, with a particular interest in mitochondrial disorders, ataxia and inherited neuropathies. Her commitment to developing new treatments in rare diseases is unwavering, most recently through new gene therapy approaches that she has established in Cambridge.